Onconova Therapeutics, Inc. Announces Listing Transfer to NASDAQ Capital Market
Feb 04, 2016 22:01 pm UTC| Business
NEWTOWN, Pa., Feb. 04, 2016 -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, today announced that it received...
Feb 04, 2016 22:01 pm UTC| Business
ST. LOUIS, Feb. 04, 2016 -- Post Holdings, Inc. (NYSE:POST), a consumer packaged goods holding company, reported results today for the fiscal quarter ended December 31, 2015. Highlights: Net sales of $1.2 billion and...
LINN Energy Announces Process to Explore Strategic Alternatives Related to Its Capital Structure
Feb 04, 2016 22:00 pm UTC| Business
HOUSTON, Feb. 04, 2016 -- LINN Energy, LLC (NASDAQ:LINE) (“LINN” or the “Company”) and LinnCo, LLC (NASDAQ:LNCO) announced today that it has initiated a process to explore strategic alternatives to strengthen its...
ACETO Reports Fiscal 2016 Second Quarter Results
Feb 04, 2016 22:00 pm UTC| Business
PORT WASHINGTON, N.Y., Feb. 04, 2016 -- ACETO Corporation (Nasdaq:ACET), an international company engaged in the marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance...
Hudson Global Schedules Conference Call and Webcast
Feb 04, 2016 22:00 pm UTC| Business
NEW YORK, Feb. 04, 2016 -- Hudson Global, Inc. (Nasdaq:HSON), a leading global talent solutions company, will issue its fourth quarter and full year financial results for the period ended December 31, 2015 at 7 a.m. ET...
Erickson Renews Second Timber Harvesting Contract
Feb 04, 2016 22:00 pm UTC| Business
PORTLAND, Ore., Feb. 04, 2016 -- Erickson Incorporated (NASDAQ:EAC), a leading global provider of aviation services, has renewed a longstanding contract for aerial timber harvesting with Vancouver-based Western Forest...
Aegerion Pharmaceuticals Announces Presentation at the Leerink Partners Global Healthcare Conference
Feb 04, 2016 21:45 pm UTC| Business
CAMBRIDGE, Mass., Feb. 04, 2016 -- Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare...